Advertisement

Topics

Trovagene seeks FDA approval of acute myeloid leukemia drug

05:04 EDT 29 Jun 2017 | SmartBrief

An investigational new drug application has been filed by Trovagene for its Phase Ib/II study assessing PCM-075 for treatment -More

Original Article: Trovagene seeks FDA approval of acute myeloid leukemia drug

NEXT ARTICLE

More From BioPortfolio on "Trovagene seeks FDA approval of acute myeloid leukemia drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...